Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

MabVax Therapeutics Holdings Revenue 2010-2018 | MBVXQ

MabVax Therapeutics Holdings revenue from 2010 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  
MabVax Therapeutics Holdings Annual Revenue
(Millions of US $)
2017 $
2016 $0
2015 $1
2014 $0
2013 $0
2012 $
2011 $
2010 $
2009 $
MabVax Therapeutics Holdings Quarterly Revenue
(Millions of US $)
2018-09-30 $4
2018-06-30 $1
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31 $0
2015-12-31 $1
2015-09-30 $0
2015-06-30 $0
2015-03-31 $0
2014-12-31 $0
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $0.000B
MabVax Therapeutics Holdings, Inc. is a clinical-stage drug development company. It is focused on discovering and developing small molecule drugs to treat cancer. TELINTRA is the Company's lead small molecule product candidate in clinical development for the treatment of blood disorders, including cancer. MabVax Therapeutics Holdings, Inc., formerly known as Telik, Inc., is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.863B 31.25
Chugai Pharmaceutical (CHGCY) Japan $52.640B 23.53
Takeda Pharmaceutical (TAK) Japan $42.029B 6.81
Merck (MKGAF) Germany $21.814B 20.58
Astellas Pharma (ALPMY) Japan $18.187B 28.71
Neurocrine Biosciences (NBIX) United States $14.410B 39.45
Sandoz Group AG (SDZNY) Switzerland $14.309B 0.00
Shionogi (SGIOY) Japan $14.080B 12.63
United Therapeutics (UTHR) United States $11.808B 12.59
Catalent (CTLT) United States $10.230B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.673B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.011B 7.71
Revolution Medicines (RVMD) United States $6.629B 0.00
Ionis Pharmaceuticals (IONS) United States $5.966B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Madrigal Pharmaceuticals (MDGL) United States $4.639B 0.00
Alpine Immune Sciences (ALPN) United States $4.238B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.753B 0.00
Summit Therapeutics (SMMT) United States $3.728B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.097B 0.00
Corcept Therapeutics (CORT) United States $2.549B 23.09
Indivior (INDV) United States $2.440B 11.57
PTC Therapeutics (PTCT) United States $2.438B 0.00
Dyne Therapeutics (DYN) United States $2.241B 0.00
Ardelyx (ARDX) United States $2.166B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.063B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.999B 11.42
NewAmsterdam Pharma (NAMS) Netherlands $1.982B 0.00
Evotec AG (EVO) Germany $1.821B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.816B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.787B 18.46
Avadel Pharmaceuticals (AVDL) Ireland $1.647B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.594B 27.91
Soleno Therapeutics (SLNO) United States $1.564B 0.00
Xencor (XNCR) United States $1.494B 0.00
4D Molecular Therapeutics (FDMT) United States $1.371B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.271B 11.94
Pacira BioSciences (PCRX) United States $1.233B 11.73
Collegium Pharmaceutical (COLL) United States $1.220B 7.51
Enliven Therapeutics (ELVN) United States $1.161B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.085B 0.00
Cronos Group (CRON) Canada $1.009B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.974B 0.00
Cassava Sciences (SAVA) United States $0.944B 0.00
ARS Pharmaceuticals (SPRY) United States $0.918B 0.00
Ocular Therapeutix (OCUL) United States $0.918B 0.00
Relay Therapeutics (RLAY) United States $0.895B 0.00
USANA Health Sciences (USNA) United States $0.859B 13.94
Sage Therapeutics (SAGE) United States $0.781B 0.00
Siga Technologies (SIGA) United States $0.744B 9.51
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.730B 0.00
Savara (SVRA) United States $0.727B 0.00
Silence Therapeutics (SLN) United Kingdom $0.664B 0.00
Lyell Immunopharma (LYEL) United States $0.648B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.615B 0.00
Exscientia (EXAI) United Kingdom $0.601B 0.00
ProKidney (PROK) United States $0.548B 0.00
OmniAb (OABI) United States $0.538B 0.00
Larimar Therapeutics (LRMR) United States $0.519B 0.00
Verve Therapeutics (VERV) United States $0.517B 0.00
Altimmune (ALT) United States $0.515B 0.00
KalVista Pharmaceuticals (KALV) United States $0.514B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.463B 0.00
Esperion Therapeutics (ESPR) United States $0.449B 0.00
Lexeo Therapeutics (LXEO) United States $0.442B 0.00
Korro Bio (KRRO) United States $0.433B 0.00
Heron Therapeutics (HRTX) United States $0.432B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.418B 0.00
Bioventus (BVS) United States $0.405B 15.52
Tourmaline Bio (TRML) United States $0.405B 0.00
Harrow (HROW) United States $0.387B 0.00
Black Diamond Therapeutics (BDTX) United States $0.378B 0.00
Nature's Sunshine Products (NATR) United States $0.360B 22.76
Verrica Pharmaceuticals (VRCA) United States $0.325B 0.00
Organogenesis (ORGO) United States $0.322B 61.00
Aquestive Therapeutics (AQST) United States $0.308B 0.00
Fractyl Health (GUTS) United States $0.305B 0.00
Nanobiotix S.A (NBTX) France $0.302B 0.00
ESSA Pharma (EPIX) Canada $0.302B 0.00
Akebia Therapeutics (AKBA) United States $0.293B 0.00
Eliem Therapeutics (ELYM) United States $0.283B 0.00
Xeris Biopharma Holdings (XERS) United States $0.279B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.277B 0.00
Nektar Therapeutics (NKTR) United States $0.275B 0.00
Pyxis Oncology (PYXS) United States $0.258B 0.00
Adherex Technologies (FENC) United States $0.255B 0.00
Aldeyra Therapeutics (ALDX) United States $0.248B 0.00
Metagenomi (MGX) United States $0.242B 0.00
Avita Medical (RCEL) United States $0.242B 0.00
Foghorn Therapeutics (FHTX) United States $0.240B 0.00
Conduit Pharmaceuticals (CDT) United States $0.237B 0.00
Zevra Therapeutics (ZVRA) United States $0.225B 0.00
Century Therapeutics (IPSC) United States $0.218B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.209B 0.00
Galectin Therapeutics (GALT) United States $0.207B 0.00
Acrivon Therapeutics (ACRV) United States $0.189B 0.00
Telomir Pharmaceuticals (TELO) United States $0.186B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
MediWound (MDWD) Israel $0.180B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Achieve Life Sciences (ACHV) Canada $0.162B 0.00
Prelude Therapeutics (PRLD) United States $0.156B 0.00
Incannex Healthcare (IXHL) Australia $0.152B 0.00
CytoDyn (CYDY) United States $0.147B 0.00
Regulus Therapeutics (RGLS) United States $0.146B 0.00
Elite Pharmaceuticals (ELTP) United States $0.144B 13.50
FibroGen (FGEN) United States $0.136B 0.00
Cardiol Therapeutics (CRDL) Canada $0.135B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.134B 2.81
VAXART, INC (VXRT) United States $0.131B 0.00
Karyopharm Therapeutics (KPTI) United States $0.128B 0.00
Inotiv (NOTV) United States $0.121B 0.00
OptiNose (OPTN) United States $0.116B 0.00
Relmada Therapeutics (RLMD) United States $0.115B 0.00
PMV Pharmaceuticals (PMVP) United States $0.112B 0.00
Citius Pharmaceuticals (CTXR) United States $0.109B 0.00
Assertio Holdings (ASRT) United States $0.106B 4.83
Aclaris Therapeutics (ACRS) United States $0.096B 0.00
Vivani Medical (VANI) United States $0.095B 0.00
AlloVir (ALVR) United States $0.092B 0.00
ProPhase Labs (PRPH) United States $0.091B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Jaguar Animal Health (JAGX) United States $0.082B 0.00
Tempest Therapeutics (TPST) United States $0.080B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.078B 0.00
SCYNEXIS (SCYX) United States $0.070B 1.04
Journey Medical (DERM) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.065B 0.00
Champions Oncology (CSBR) United States $0.064B 0.00
Carisma Therapeutics (CARM) United States $0.064B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
BioLineRx (BLRX) Israel $0.055B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Unicycive Therapeutics (UNCY) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
VYNE Therapeutics (VYNE) United States $0.041B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.039B 0.00
JanOne (JAN) United States $0.039B 0.00
DURECT (DRRX) United States $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.036B 0.00
CASI Pharmaceuticals (CASI) China $0.035B 0.00
Protara Therapeutics (TARA) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
Surrozen (SRZN) United States $0.032B 0.00
NRx Pharmaceuticals (NRXP) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Lipocine (LPCN) United States $0.027B 0.00
Nutriband (NTRB) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Lyra Therapeutics (LYRA) United States $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.025B 0.00
PolyPid (PYPD) Israel $0.023B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.021B 1.05
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
GlycoMimetics (GLYC) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
CERo Therapeutics Holdings (CERO) United States $0.019B 0.00
Aptorum Group (APM) United Kingdom $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.016B 0.00
Mannatech (MTEX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Inhibikase Therapeutics (IKT) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Acutus Medical (AFIB) United States $0.004B 0.00
Clever Leaves Holdings (CLVR) Canada $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.27
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.58